我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

氢气（H2）的血管保护效应及其研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2014年第3期
页码:
348-352
栏目:
综述
出版日期:
2014-03-20

文章信息/Info

Title:
Research advances in the vascular protective effect of H2
作者:
张亚星; 王庭槐
(中山大学中山医学院生理学教研室，广东 广州 510080)
Author(s):
ZHANG Ya xing;  WANG Ting huai
(Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China)
关键词:
氢气; 氧化应激; 动脉粥样硬化; 血管保护
Keywords:
hydrogen gas;  oxidative stress;  atherosclerosis;  angiogenesis
分类号:
R979.9
DOI:
-
文献标识码:
A
摘要:
氧化应激在心血管疾病的发生、发展中起着重要的作用。空气中最轻的气体分子氢气作为一种有效的抗氧化剂能够快速的扩散入组织和细胞，有效地抑制与氧化应激有关的血管疾病如动脉粥样硬化、血管内膜异常增生、角膜血管及视网膜血管新生等，为血管疾病的防治提供了崭新的思路。
Abstract:
Oxidative stress plays an important role in the development of cardiovascular diseases. Hydrogen gas (H2), which is the smallest molecule in the atmosphere, has the character of reduction and is easily diffused into the tissues and cells, thus inhibiting some diseases related to oxidative stress such as atherosclerosis, paraplasm of endangium, angiogenesis of cornea and angiogenesis of retina. H2, a novel bioactive molecule, sheds some new light on the prevention and treatment of cardiovascular diseases.

参考文献/References

[1]Madamanchi NR,Runge MS.Redox signaling in cardiovascular health and disease[J].Free Radic Biol Med,2013,61C:473-501.
[2]Levonen AL,V?h?kangas E,Koponen JK,et al.Antioxidant gene therapy for cardiovascular disease:current status and future perspectives[J].Circulation.2008,117(16):2142-2150.
[3]Ohsawa I,Ishikawa M,Takahashi K,et al.Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals[J].Nat Med,2007,13(6):688-694.
[4]Ohsawa I,Nishimaki K,Yamagata K,et al.Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice[J].Biochem Biophys Res Commun,2008,377(4):1195-1198.
[5]Ekuni D,Tomofuji T,Endo Y,et al.Hydrogen-rich water prevents lipid deposition in the descending aorta in a rat periodontitis model[J].Arch Oral Biol,2012,57(12):1615-1622.
[6]Song G,Tian H,Qin S,et al.Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice[J].Atherosclerosis,2012,221(1):55-65.
[7]Zong C,Song G,Yao S,et al.Administration of hydrogensaturated saline decreases plasma low-density lipoprotein cholesterol levels and improves high-density lipoprotein function in high-fat diet-fed hamsters[J].Metabolism,2012,61(6):794-800.
[8]Song G,Tian H,Liu J,et al.H2 inhibits TNF-α-induced lectin-like oxidized LDL receptor-1 expression by inhibiting nuclear factor κB activation in endothelial cells[J].Biotechnol Lett,2011,33(9):1715-1722.
[9]Sun Q,Kawamura T,Masutani K,et al.Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats[J].Cardiovasc Res,2012,94(1):144-153.
[10]Qin ZX,Yu P,Qian DH,et al.Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway[J].Atherosclerosis,2012,220(2):343-350.
[11]Chen Y,Jiang J,Miao H,et al.Hydrogen-rich saline attenuates vascular smooth muscle cell proliferation and neointimal hyperplasia by inhibiting reactive oxygen species production and inactivating the Ras-ERK1/2-MEK1/2 and Akt pathways[J].Int J Mol Med,2013,31(3):597-606.
[12]Wang Y,Jing L,Zhao XM,et al.Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model[J].Respir Res,2011,12:26.
[13]Zheng H,Yu YS.Chronic hydrogen-rich saline treatment attenuates vascular dysfunction in spontaneous hypertensive rats[J].Biochem Pharmacol,2012,83(9):1269-1277.
[14]Kubota M,Shimmura S,Kubota S,et al.Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse cornealalkali-burn model[J].Invest Ophthalmol Vis Sci,2011,52(1):427-433.
[15]Huang L,Zhao S,Zhang JH,et al.Hydrogen saline treatment attenuates hyperoxia-induced retinopathy by inhibition of oxidative stress and reduction of VEGF expression[J].Ophthalmic Res,2012,47(3):122-127.
[16]Ohta S.Recent advances in hydrogen research as a therapeutic medical gas[J].Curr Pharm Des,2011,17(22): 2241-2252.
[17]Nakao A,Sugimoto R,Billiar TR,et al.Therapeutic antioxidant medical gas[J].J Clin Biochem Nutr,2009,44(1):1-13.
[18]Tonetti MS,D'Aiuto F,Nibali L,et al.Treatment of periodontitis and endothelial function[J].N Engl J Med,2007,356(9):911-920.
[19]Kajiyama S,Hasegawa G,Asano M,et al.Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance[J].Nutr Res,2008,28(3):137-143.
[20]Tamaki N,Tomofuji T,Ekuni D,et al.Periodontal treatment decreases plasma oxidized LDL level and oxidative stress[J].Clin Oral Investig,2011,15(6):953-958.
[21]Cairo F,Castellani S,Gori AM,et al.Severe periodontitis in young adults is associated with sub-clinical atherosclerosis[J].J Clin Periodontol,2008,35(6):465-472.
[22]Friedewald VE,Kornman KS,Beck JD,et al.The American Journal of Cardiology and Journal of Periodontology editors'consensus:periodontitis and atherosclerotic cardiovascular disease[J].J Periodontol,2009,80(7):1021-1032.
[23]Fang C,Lei J,Zhou SX,et al.Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension[J].Chin Med J(Engl),2013, 126(4):646-649.
[24]Heo KS,Chang E,Le NT,et al.De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis[J].Circ Res,2013,112(6):911-923.
[25]Le NT,Heo KS,Takei Y,et al.A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis[J].Circulation, 2013,127(4):486-499.
[26]Zheng H,Yu YS.Chronic hydrogen-rich saline treatment attenuates vascular dysfunction in spontaneous hypertensive rats[J].Biochem Pharmacol,2012,83(9):1269-1277.
[27]Xu S,Ogura S,Chen J,et al.LOX-1 in atherosclerosis:biological functions and pharmacological modifiers[J].Cell Mol Life Sci,2013,70(16):2859-2872.
[28]Noda K,Tanaka Y,Shigemura N,et al.Hydrogen-supplemented drinking water protects cardiac allografts from inflammation-associated deterioration[J].Transpl Int,2012,25(12):1213-1222.
[29]Ghatnekar A,Chrobak I,Reese C,et al.Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension[J].Am J Pathol,2013,182(6):2391-2406.
[30]Sanchez O,Humbert M,Sitbon O,et al.Guidelines for the diagnosis and treatment of pulmonary hypertension[J].Rev Mal Respir,2010,27(2):141-150.
[31]Giacco F,Brownlee M.Oxidative stress and diabetic complications[J].Circ Res,2010,107(9):1058-1070.
[32]Wilkinson-Berka JL,Rana I,Armani R,et al.Reactive oxygen species,Nox and angiotensin II in angiogenesis:implications for retinopathy[J].Clin Sci (Lond),2013,124(10):597-615.
[33]Lee K,Hu Y,Ding L,et al.Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy[J].Diabetes,2012,61(11):2948-2957.
[34]Kajiya M,Sato K,Silva MJ,et al.Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis[J].Biochem Biophys Res Commun,2009,386(2):316-321.
[35]Szabó C.Hydrogen sulphide and its therapeutic potential[J].Nat Rev Drug Discov,2007,6(11):917-935.
[36]Johnson RA,Kozma F,Colombari E.Carbon monoxide: from toxin to endogenous modulator of cardiovascular functions[J].Braz J Med Biol Res,1999,32(1):1-14.
[37]Dimmeler S,Fleming I,Fisslthaler B,et al.Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation[J].Nature, 1999,399(6736):601-605.

备注/Memo

备注/Memo:
收稿日期：2013-09-03.
通讯作者：王庭槐，教授，主要从事心血管生理学和生物反馈研究 Email：wangth@mail.sysu.edu.cn
作者简介：张亚星，博士生 Email：zhangyaxingstar@126.com
更新日期/Last Update: 2014-03-21